ClinicalTrials.Veeva

Menu

Therapy Protocol Acute Lymphoblastic Leukemia Stem Cell Transplantation International (ALL SCT BFM)

H

Hadassah Medical Center

Status

Completed

Conditions

Acute Lymphoblastic Leukemia

Treatments

Procedure: Transplantation with Stem Cells from Umbilical Cord

Study type

Interventional

Funder types

Other

Identifiers

NCT00861679
ALL-SCT-BFM-0321-08-HMO-CTIL

Details and patient eligibility

About

To evaluate whether HSCT from matched family or unrelated donors (MD) is equivalent to the HSCT from matched sibling donors (MSD). To evaluate the efficacy of HSCT from mismatched family or unrelated donors (MMD) as compared to HSCT from MSD/MD. To determine whether therapy has been carried out according to the main HSCT protocol recommendations. The standardisation of the treatment options during HSCT from different donor types aims at the achievement of an optimal comparison of survival after HSCT with survival after chemotherapy only. To prospectively evaluate and compare the incidence of acute and chronic GvHD after HSCT from MSD, from MD and from MMD.

Enrollment

552 patients

Sex

All

Ages

Under 18 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

all patients with ALL (except for patients with B-ALL) who fulfil the following criteria:

  • age at time of initial diagnosis or relapse diagnosis, respectively

    ≤18 years

  • indication for allogeneic HSCT

  • complete remission (CR) is achieved before SCT

  • written consent of the parents (legal guardian) and, if indicated, the minor patient via "Informed Consent Form"

  • no pregnancy

  • no secondary malignancy

  • no previous HSCT

  • HSCT is performed in a study participating centre.

Exclusion criteria

  • not signed inform consent of the parents (legal guardian)
  • pregnancy
  • secondary malignancy
  • previous HSCT

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

552 participants in 1 patient group

HSCT from matched family or unrelated donors(MD)
Other group
Description:
HSCT from matched family or unrelated donors(MD) to matched related donors.
Treatment:
Procedure: Transplantation with Stem Cells from Umbilical Cord

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems